Diligence memo · auto-generated · as of July 2, 2026
Intron Health
Intron Health looks over-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Intron Health operates in Healthtech, based in Nigeria, Africa. Nigerian startup Intron Health, which provides clinical speech recognition for over 200 accents spoken in developing countries, starting in Africa, has raised US$1.6 million in a pre-seed funding round to deepen its research and expand distribution.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Intron Health has raised $1.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.6M on 2024-07-29.
Most recent recorded round closed around 2024-07-29.
Valuation (modeled)modeled
Provath models Intron Health at approximately $6.8M (range $1.0M–$22M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.42× the median modeled value of Pre-Seed Healthtech companies in 2022–2024 (174 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 23 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 35% of Healthtech peers (2138 compared).
Modeled value ranks above 27% of those peers.
Closest niche peers: Hoy Health Corp, Ennova Health LLC, Telebelly Health, Inc., Health Rosetta Group PBC, B2M Medical, Inc..
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.